HLA-B27 Testing in Clinical Practice: A Retrospective Analysis of Testing Indications and Rheumatology Referral Patterns
- 1 June 2025
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 52 (10) , 1021-1027
Abstract
Objective: The HLA-B27 allele is strongly associated with spondyloarthritis (SpA). HLA-B27 is included in SpA classification criteria and referral strategies for axial SpA. Investigations of HLA-B27 testing in usual clinical practice are limited. Methods: We identified all adult patients tested for HLA-B27 from January 1, 2022, to December 31, 2022, in the Mass General Brigham healthcare system. We examined patient demographics; ordering provider specialty; testing indication; concurrent testing with antinuclear antibodies (ANA), rheumatoid factor, and/or anticyclic citrullinated peptide autoantibodies; and rheumatology referral. We compared the rate of rheumatology referral between HLA-B27–positive and HLA-B27–negative patients. Results: HLA-B27 tests were ordered for 1960 patients (62.4% female; average age: 47.4 yrs). The most common specialties testing HLA-B27 were rheumatology (39.7%) and ophthalmology (21.4%). The most common indications for HLA-B27 testing were peripheral arthritis (33%), uveitis (22%), and back pain (16.7%). The majority of HLA-B27 tests (69.3%) were ordered concurrently with other autoantibody tests. A total of 11% of tested patients were HLA-B27 positive. Ophthalmology had the highest positive rate (15.4%), whereas reactive arthritis was the indication with the highest positive test rate (50%). A greater proportion of HLA-B27–positive patients were referred to rheumatology (53% vs 32%; P = 0.002). Conclusion: HLA-B27 testing was frequently performed by rheumatologists and nonrheumatologists for a broad spectrum of indications. Cotesting HLA-B27 with ANA and rheumatoid arthritis autoantibodies was common. Nearly half of HLA-B27–positive patients were not referred to rheumatology. Further efforts are needed to promote judicious use of HLA-B27 testing and optimize referral pathways to rheumatology.Keywords
This publication has 29 references indexed in Scilit:
- Screening Tools for Spondyloarthritis in Patients With Psoriasis, Uveitis, and Inflammatory Bowel Disease: A Scoping ReviewArthritis Care & Research, 2024
- What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back painJoint Bone Spine, 2023
- Appropriateness of laboratory tests in the diagnosis of inflammatory rheumatic diseases among patients newly referred to rheumatologistsJoint Bone Spine, 2020
- Understanding Barriers in the Pathway to Diagnosis of Ankylosing Spondylitis: Results From a US Survey of 1690 Physicians From 10 SpecialtiesACR Open Rheumatology, 2020
- Acute anterior uveitis and undiagnosed spondyloarthritis: usefulness of Berlin criteriaGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should questionArthritis Care & Research, 2013
- HL-A 27 AND ARTHROPATHIES ASSOCIATED WITH ULCERATIVE COLITIS AND PSORIASISThe Lancet, 1974
- REITER'S DISEASE AND HL-A 27The Lancet, 1973
- ACUTE ANTERIOR UVEITIS AND HL-A 27The Lancet, 1973
- ANKYLOSING SPONDYLITIS AND HL-A 27The Lancet, 1973